B05 Measles

Name of the Condition

• Measles

Summary

Measles is a highly contagious viral infection characterized by a distinctive rash, fever, and respiratory symptoms. It primarily affects the respiratory tract and skin, with potential for systemic involvement. The condition is preventable through vaccination and typically follows a predictable clinical course, though complications can occur, especially in vulnerable populations.

Causes

Measles is caused by the measles virus, a member of the Paramyxoviridae family. Transmission occurs through respiratory droplets or direct contact with infected secretions. The virus replicates in the respiratory epithelium before spreading to lymphoid tissues and the skin, leading to the characteristic symptoms and rash.

Risk Factors

• Lack of vaccination or incomplete immunization.
• Close contact with an infected individual, particularly in crowded settings.
• Immunocompromised states, such as HIV/AIDS, chemotherapy, or chronic steroid use.
• Age, with infants and young children at increased risk for severe disease.
• Malnutrition or vitamin A deficiency, which may worsen outcomes.

Symptoms

• High fever, often exceeding 104°F (40°C).
• Cough, coryza (runny nose), and conjunctivitis (red, watery eyes).
• Koplik spots (small white lesions) on the inside of the cheeks.
• Maculopapular rash that starts on the face and spreads downward to the body.
• Generalized malaise and fatigue.

Diagnosis

Diagnosis is typically based on clinical presentation, including the characteristic rash and symptoms. Laboratory confirmation may involve detecting measles-specific IgM antibodies in blood or viral RNA via polymerase chain reaction (PCR) from respiratory samples. Serology or viral culture may also be used in atypical cases.

Treatment Options

Treatment is primarily supportive, focusing on symptom relief and preventing complications. This includes rest, hydration, and fever management. Vitamin A supplementation is recommended for children in developing countries or those with malnutrition. Antiviral therapy is not routinely used, and antibiotics are only indicated for secondary bacterial infections.

Prognosis and Follow-Up

Most healthy individuals recover fully within 2–3 weeks. Follow-up is important to monitor for complications, especially in high-risk groups. Long-term immunity is usually conferred after infection, though vaccination is preferred for prevention. Severe cases or complications may require extended care and monitoring.

Complications

• Pneumonia, the most common cause of measles-related death.
• Encephalitis, which can lead to neurological damage.
• Otitis media or bacterial superinfections.
• Subacute sclerosing panencephalitis (rare, late-onset complication).
• Diarrhea and dehydration, particularly in young children.

Lifestyle & Prevention

• Vaccination with the measles-mumps-rubella (MMR) vaccine is the most effective prevention.
• Avoiding close contact with infected individuals during outbreaks.
• Practicing good hygiene, such as handwashing.
• Ensuring adequate nutrition, especially vitamin A, to support immune function.

When to Seek Professional Help

Seek immediate medical attention if experiencing high fever, difficulty breathing, persistent cough, or signs of dehydration. Consult a healthcare provider if symptoms worsen or if there is concern about complications, especially in unvaccinated individuals or those with weakened immune systems.

Tips for Medical Coders

When coding for measles (B05), ensure documentation supports the diagnosis, including clinical symptoms, laboratory confirmation, or exposure history. Note any complications or associated conditions, as these may require additional codes. Follow guidelines for reporting confirmed, probable, or suspected cases based on clinical and laboratory findings.